About the Authors
- Esther Nkuipou-Kenfack
-
Affiliations Mosaiques Diagnostics GmbH, Hannover, Germany, Department of Toxicology, Hannover Medical School, Hannover, Germany
- Flore Duranton
-
Affiliation RD Néphrologie, Montpellier, France
- Nathalie Gayrard
-
Affiliation RD Néphrologie, Montpellier, France
- Àngel Argilés
-
Affiliations RD Néphrologie, Montpellier, France, Néphrologie Dialyse St Guilhem, Séte, France, Service de Néphrologie, Dialyse Péritonéale et Transplantation, Montpellier, France
- Ulrika Lundin
-
Affiliation Biocrates life sciences AG, Innsbruck, Austria
- Klaus M. Weinberger
-
Affiliations Biocrates life sciences AG, Innsbruck, Austria, sAnalytiCo Ltd, Belfast, United Kingdom, Department of Biomedical Informatics and Mechatronics, Private University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria
- Mohammed Dakna
-
Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany
- Christian Delles
-
Affiliation BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
- William Mullen
-
Affiliation BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
- Holger Husi
-
Affiliation BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
- Julie Klein
-
Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany
- Thomas Koeck
-
Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany
- Petra Zürbig
-
Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany
- Harald Mischak
-
* E-mail: mischak@mosaiques-diagnostics.com
Affiliations Mosaiques Diagnostics GmbH, Hannover, Germany, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
Competing Interests
H. Mischak is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology for clinical application. E. Nkuipou-Kenfack, M. Dakna, J. Klein, T. Koeck, and P. Zürbig are employees of Mosaiques Diagnostics. U. Lundin was an employee of Biocrates Life Sciences AG. K. Weinberger is a shareholder and consultant of Biocrates Life Sciences AG, who developed the metabolomics platform and kit products for research and diagnostic applications. These issues do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ENK AA HM KW. Performed the experiments: WM NG UL KW. Analyzed the data: MD ENK JK HH PZ TK HM FD AA UL KW. Contributed reagents/materials/analysis tools: HM AA KW. Wrote the paper: ENK HM JK TK CD PZ AA FD MD KW.